Transcutaneous PO2 monitoring in infants with cyanotic congenital heart disease treated with prostaglandin E1
- 1 April 1983
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 4 (2) , 87-89
- https://doi.org/10.1007/bf02076331
Abstract
Transcutaneous PO2 (tcPO2) has been shown to closely approximate arterial PO2 (PaO2) in infants with normal oxygenation (PaO2 60–100 mm Hg). During hypoxemia (PaO22 monitoring is of little value. We examined the relationship of tcPO2 to PaO2 among 6 infants with cyanotic congenital heart disease who were receiving prostaglandin E1 (PGE1). Close, linear correlation was found, even during hypoxemia. We conclude that tcPO2 monitoring has potential clinical value in such patients.Keywords
This publication has 13 references indexed in Scilit:
- TRANSCUTANEOUS Po2MONITORING IN NEONATAL INTENSIVE CAREActa Paediatrica, 1978
- Comparison of Transcutaneous Oxygen Tension With Arterial Oxygen Tension in Newborn Infants With Severe Respiratory IllnessesPediatrics, 1978
- Transcutaneous PO2 monitoring in infants with persistent fetal circulation who are receiving tolazoline therapy.1978
- TRANS-CUTANEOUS OXYGEN-TENSION IN SICK INFANTSPublished by Elsevier ,1978
- Cutaneous pO2-measurements in newborns with respiratory distress syndrome.1976
- Letter: Reliability of transcutaneous PO2 with Roche Oxygen Monitor 5300 at 44 C in newborn infants with RDS.1976
- Transcutaneous Po2 Monitoring in Routine Management of Infants and Children With Cardiorespiratory ProblemsPediatrics, 1976
- Transcutaneous Determination of Arterial Oxygen TensionPediatrics, 1975
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975
- Prostaglandins and the circulation.1971